#28: Long COVID affects millions worldwide—but what’s really happening inside the body? In this episode of The Science of Sound, host Aaron Fournier sits down with Dr. Paul Harris, Functional Medicine Detective and medical director at Soaak Technologies, to explore how viruses hijack cells, disrupt ATP energy production, and create lasting symptoms like fatigue, brain fog, cardiovascular stress, and immune dysregulation.

Dr. Harris explains how long COVID impacts the hypothalamus, nervous system, and immune seesaw between Th1 and Th2 responses, often leading to autoimmune activity and chronic inflammation. He shares insights on functional medicine strategies—including advanced lab testing, mitochondrial support, fasting, NAC supplementation, Fatty C15, binders, and the role of sound frequencies—in restoring balance and coherence to the body. If you or someone you love has struggled with lingering COVID symptoms, this conversation provides both hope and practical direction.

00:00 Introduction

02:17 Meet Dr. Paul Harris

04:34 How Viruses Enter Cells

06:51 Long COVID Symptoms Explained

09:08 Fatigue, Brain Fog, and Stress Connection

11:25 Impact on Mitochondria and ATP Production

13:42 Fasting, Healing, and Immune Reset

15:59 Organ Systems Affected by Long COVID

18:16 Cardiovascular Complications and PET Scans

20:33 Autonomic Nervous System Imbalance

22:50 Autoimmunity and Three Stages of Progression

25:07 TH1 vs TH2 Immune System Balance

27:24 Functional Medicine vs Conventional Medicine

29:41 Supplements and Nutraceutical Approaches

31:58 NAC, C15, and Repairing Cell Membranes

34:15 Cardiovascular Endothelial Damage Explained

36:32 Gut Health, Leaky Gut, and Brain Fog

38:49 Detox Pathways and Protein Cleanse

41:06 Closing Thoughts and Outro

Follow Soaak & The Science of Sound Podcast:

• Website – Soaak Technologies

• App – Soaak Frequency Therapy

• Instagram – @thesoaakpodcast

Sponsors:

Visit soaak.com/app and enter code Soaakpod for your first month free!

Produced by Soaak Technologies Inc.